Loading
Latest filing published 20 Dec 2022 for ZyVersa Therapeutics, Inc., €8,124. Read the official filing
No signal scores available.
All filings by Peter Wolfe on record concern ZyVersa Therapeutics, Inc. Between 12 December 2022 and 16 December 2022, the trades on record add up to 2 filings.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
Most recently, on 20 December 2022, the filings show a share grant worth €8,124 in ZyVersa Therapeutics, Inc. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations